Browsing Over 146 Presentations
Sort By
New indications in CNS tumours (ID 2)
Educational session
Vaccine strategies for gliomas (ID 9)
Lecture Time
14:50 - 15:10
Speakers
- Michael Platten (Mannheim, DE)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Michael Platten (Mannheim, DE)
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
What are the long terms risk of peri-operative immune therapy and how much benefit is required to offset this? (ID 4)
Lecture Time
14:50 - 15:10
Speakers
- Brian I. Rini (Nashville, US)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Brian I. Rini (Nashville, US)
New indications in CNS tumours (ID 2)
Educational session
CAR T-cells for brain tumours (ID 10)
Lecture Time
15:10 - 15:30
Speakers
- Denis Migliorini (Geneva, CH)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Denis Migliorini (Geneva, CH)
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
Biomarkers for immune checkpoint inhibitors in the perioperative setting in breast cancer (ID 5)
Lecture Time
15:10 - 15:30
Speakers
- Michail Ignatiadis (Brussels, BE)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Michail Ignatiadis (Brussels, BE)
New indications in CNS tumours (ID 2)
Educational session
Immunotherapy of leptomeningeal metastases (ID 11)
Lecture Time
15:30 - 15:50
Speakers
- Ghazaleh Tabatabai (Tuebingen, DE)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Ghazaleh Tabatabai (Tuebingen, DE)
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
Exploring beyond PD-(L)1 therapy in peri-operative disease (ID 6)
Lecture Time
15:30 - 15:50
Speakers
- David F. McDermott (Boston, US)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- David F. McDermott (Boston, US)
New indications in CNS tumours (ID 2)
Educational session
Q&A (ID 12)
Lecture Time
15:50 - 16:00
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
Q&A (ID 7)
Lecture Time
15:50 - 16:00
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
New indications in CNS tumours (ID 2)
Educational session
Antibody-fusion constructs for the treatment of glioblastoma (ID 8)
Lecture Time
14:30 - 14:50
Speakers
- Patrick Roth (Zurich, CH)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Patrick Roth (Zurich, CH)
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
What are the right surrogate endpoints for peri-operative immune therapy (ID 3)
Lecture Time
14:30 - 14:50
Speakers
- Thomas B. Powles (London, GB)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Thomas B. Powles (London, GB)
Direct intratumoural injection of immunotherapy (ID 4)
Educational session
A multifaceted herpes simplex virus oncolytic immunotherapy platform (ID 23)
Lecture Time
17:10 - 17:30
Speakers
- Robert Coffin (Woburn, US)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
16:30 - 18:00
Authors
- Robert Coffin (Woburn, US)
Optimising I-O drug clinical development (ID 3)
Educational session
What biomarkers should we be using to give us better positive outcomes (ID 18)
Lecture Time
17:10 - 17:30
Speakers
- Samra Turajlic (London, GB)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
16:30 - 18:00
Authors
- Samra Turajlic (London, GB)